Chief Medical Officer

Dr. Glenda Pettaway, MD, MS, FAAP

Board-certified pediatrician with nearly two decades of experience, leading the clinical program behind Thryvwell's specialist weight care for young people ages 12–26.

About Dr. Pettaway

Dr. Pettaway brings nearly two decades of pediatric medicine experience to Thryvwell, including fellowship training in Pediatric Infectious Diseases at the University of Pittsburgh. As Chief Medical Officer, she designed Thryvwell's clinical protocols to align with the American Academy of Pediatrics' 2023 clinical practice guideline for the evaluation and treatment of children and adolescents with obesity, and she personally oversees the standards behind every treatment plan.

Her clinical philosophy shapes everything Thryvwell publishes and prescribes: weight is a medical topic, not a moral one. That means evidence over trends, screening before prescribing, growth and development monitored at every step, and family involvement built into a young person's care rather than bolted on.

Thryvwell's program pairs each patient with a board-certified physician from a trusted care network with expertise in adolescent and young adult weight management and GLP-1 therapies — referred by pediatricians and designed to keep your child's pediatrician informed so everyone stays aligned.

How Our Medical Review Works

Every clinical article in the Thryvwell Resource Center that carries the "medically reviewed" marker has been reviewed for clinical accuracy against current evidence — peer-reviewed trials, FDA labeling, and the AAP's published guidelines. Reviewed articles show the review attribution and date, cite primary sources, and are updated when the evidence changes.

Our editorial standard is simple: if a claim about a medication, risk, or outcome cannot be traced to a primary source, it does not get published. Where the honest answer is "the long-term data does not exist yet," we say exactly that.